# REVIEW_REPORT.md

## verdict
PASS

## criteria met
- `scripts/run_phase2_acceptance.py`, `scripts/run_phase2_readiness_gates.py`, and `scripts/run_phase2_validation_matrix.py` are now canonical implementations and no longer delegate to `run_mvp_*` scripts.
- `scripts/run_mvp_acceptance.py`, `scripts/run_mvp_readiness_gates.py`, and `scripts/run_mvp_validation_matrix.py` are explicit compatibility aliases that forward args and exit codes to the Phase 2 scripts.
- Deterministic gate semantics were preserved during migration:
  - acceptance node list is unchanged (moved from MVP runner to Phase 2 runner)
  - readiness thresholds are unchanged (`latency_p95 < 5.0`, `cache_reuse >= 0.70`, `memory precision > 0.80`, `adjudicated_sample >= 20`)
  - validation-matrix step ordering and no-go behavior remain unchanged
- `tests/unit/test_phase2_gate_wrappers.py` was updated for canonical direction and passed in reviewer execution:
  - command run: `./.venv/bin/python -m pytest tests/unit/test_phase2_gate_wrappers.py -q`
  - result: `17 passed`
- Runbooks and entry docs were aligned to “Phase 2 canonical, MVP compatibility alias” across:
  - `docs/runbooks/mvp-acceptance-suite.md`
  - `docs/runbooks/mvp-readiness-gates.md`
  - `docs/runbooks/mvp-validation-matrix.md`
  - `README.md`
  - `.ai/handoff/CURRENT_STATE.md`
- No product endpoint/API surface changes were introduced in this sprint diff.

## criteria missed
- None.

## quality issues
- None blocking.

## regression risks
- Low.
- Residual risk: if future changes update only canonical script messaging or only alias messaging, operator-facing output may drift even if execution semantics stay stable.

## docs issues
- None blocking within sprint scope.

## should anything be added to RULES.md?
- No.

## should anything update ARCHITECTURE.md?
- No.

## recommended next action
1. Approve sprint as complete and proceed with Control Tower integration sign-off.
2. In future gate changes, update Phase 2 scripts first and keep MVP alias scripts thin and argument-transparent.
